Australia markets closed

VRTX Jun 2023 130.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.71000.0000 (0.00%)
As of 10:28AM EST. Market open.
Full screen
Previous close0.7100
Open0.8000
Bid0.0000
Ask4.7000
Strike130.00
Expiry date2023-06-16
Day's range0.6000 - 0.8000
Contract rangeN/A
Volume6
Open interest13
  • Zacks

    Biotech Stocks' Q4 Earnings Due on Feb 7: VRTX, INCY and EXEL

    Let us take a look at what is in store for some of the biotech stocks VRTX, INCY and EXEL, which are scheduled to report on Feb 7.

  • Zacks

    Vertex (VRTX) to Report Q4 Earnings: What's in the Cards?

    On Vertex Pharmaceuticals' (VRTX) Q4 earnings call, investors will likely focus on the sales performance of its cystic fibrosis medicines and updates on its non-CF pipeline candidates.

  • Motley Fool

    2 Unstoppable Growth Stocks to Buy in 2023 and Beyond

    Last year's bear market made many victims among even the most prominent corporations although growth stocks fared even worse than other categories of equities. Among this small group of outperformers are two healthcare leaders: biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) and medical device expert DexCom (NASDAQ: DXCM). Let's consider why Vertex Pharmaceuticals and DexCom are excellent stocks to buy.